Herantis Pharma Plc: Update on contemplated directed share issue
Herantis Pharma Plc: Update on contemplated directed share issue Herantis Pharma PlcCompany release 12 March 2019 at 12:30 pm Not for publication or distribution, directly or indirectly, in or into Australia, South Africa, Hong Kong, Japan, Canada or the United States of America or in any other jurisdiction in which publishing or distributing would be prohibited by applicable law Herantis Pharma Plc ("Herantis" or the "Company") announces an update regarding the contemplated directed share issue first announced by a company release on 15 February 2019 (the "Directed Issue").